122 related articles for article (PubMed ID: 15363939)
1. Characterization of the effect of retinol on Plasmodium falciparum in vitro.
Hamzah J; Davis TM; Skinner-Adams TS; Beilby J
Exp Parasitol; 2004; 107(3-4):136-44. PubMed ID: 15363939
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimalarial activity of retinoids and the influence of selective retinoic acid receptor antagonists.
Hamzah J; Skinner-Adams TS; Davis TM
Acta Trop; 2003 Aug; 87(3):345-53. PubMed ID: 12875928
[TBL] [Abstract][Full Text] [Related]
3. Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro.
Burkhardt D; Wiesner J; Stoesser N; Ramharter M; Uhlemann AC; Issifou S; Jomaa H; Krishna S; Kremsner PG; Borrmann S
Int J Parasitol; 2007 Jun; 37(7):777-85. PubMed ID: 17280676
[TBL] [Abstract][Full Text] [Related]
4. In vitro growth inhibition of Plasmodium falciparum by retinol at concentrations present in normal human serum.
Davis TM; Skinner-Adams TS; Beilby J
Acta Trop; 1998 May; 69(2):111-9. PubMed ID: 9588231
[TBL] [Abstract][Full Text] [Related]
5. Selective lysis of erythrocytes infected with the trophozoite stage of Plasmodium falciparum by polyene macrolide antibiotics.
Wiehart UI; Rautenbach M; Hoppe HC
Biochem Pharmacol; 2006 Mar; 71(6):779-90. PubMed ID: 16436272
[TBL] [Abstract][Full Text] [Related]
6. In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.
Maerki S; Brun R; Charman SA; Dorn A; Matile H; Wittlin S
J Antimicrob Chemother; 2006 Jul; 58(1):52-8. PubMed ID: 16735432
[TBL] [Abstract][Full Text] [Related]
7. Anti-Plasmodium activity of ceramide analogs.
Labaied M; Dagan A; Dellinger M; Gèze M; Egée S; Thomas SL; Wang C; Gatt S; Grellier P
Malar J; 2004 Dec; 3():49. PubMed ID: 15588325
[TBL] [Abstract][Full Text] [Related]
8. [In vitro cultivation of Plasmodium falciparum. Applications and limits.- Methodology].
Druilhe P; Gentilini M
Med Trop (Mars); 1982; 42(4):437-62. PubMed ID: 6755144
[TBL] [Abstract][Full Text] [Related]
9. Requirements for maximal enrichment of viable intraerythrocytic Plasmodium falciparum rings by saponin hemolysis.
Orjih AU
Exp Biol Med (Maywood); 2008 Nov; 233(11):1359-67. PubMed ID: 18791132
[TBL] [Abstract][Full Text] [Related]
10. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Acta Trop; 2006 Dec; 100(3):185-91. PubMed ID: 17126280
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro.
Barker RH; Metelev V; Coakley A; Zamecnik P
Exp Parasitol; 1998 Jan; 88(1):51-9. PubMed ID: 9501848
[TBL] [Abstract][Full Text] [Related]
12. An in vitro assay system for the identification of potential antimalarial drugs.
Geary TG; Divo AA; Jensen JB
J Parasitol; 1983 Jun; 69(3):577-83. PubMed ID: 6355423
[TBL] [Abstract][Full Text] [Related]
13. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
Yanow SK; Purcell LA; Spithill TW
Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
[TBL] [Abstract][Full Text] [Related]
14. Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx.
Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga S; Vial H
Mol Biochem Parasitol; 2006 Mar; 146(1):58-67. PubMed ID: 16313982
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of "hydrophobic groupings" and the role of carbohydrates in Plasmodium falciparum infection.
Hermentin P; Neunziger G; Paulsen H; Kolar C; Seiler FR; Dahr W; Enders B
Behring Inst Mitt; 1986 Jun; (80):64-73. PubMed ID: 3530236
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial activity of natural product extracts from Papua New Guinean and Australian plants against Plasmodium falciparum.
Fernandez LS; Jobling MF; Andrews KT; Avery VM
Phytother Res; 2008 Oct; 22(10):1409-12. PubMed ID: 18693292
[TBL] [Abstract][Full Text] [Related]
17. One-step Plasmodium falciparum cultivation--application to in-vitro drug testing.
Druilhe P; Mazier D; Brandicourt O; Gentilini M
Tropenmed Parasitol; 1983 Dec; 34(4):233-4. PubMed ID: 6364513
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the rate of asexual growth and commitment to sexual development by diffusible factors from in vitro cultures of Plasmodium falciparum.
Dyer M; Day KP
Am J Trop Med Hyg; 2003 Apr; 68(4):403-9. PubMed ID: 12875287
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
[TBL] [Abstract][Full Text] [Related]
20. The potential use of methotrexate in the treatment of falciparum malaria: in vitro assays against sensitive and multidrug-resistant falciparum strains.
Dar O; Khan MS; Adagu I
Jpn J Infect Dis; 2008 May; 61(3):210-1. PubMed ID: 18503171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
